Bioherent Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Early Stage VC
- Investors
-
4
Bioherent General Information
Description
Developer of photonic biosensors for the diagnosis of drug allergies intended to revolutionize drug allergy tests. The company's platform utilizes integrated silicon interferometry for real-time detection and nanoscale precision, offering a suite of products including diagnostic instruments, specialized nanoparticles for molecular detection, and original equipment manufacturer biosensor modules for research and clinical applications, enabling healthcare providers and researchers to achieve accurate diagnostic results and improve patient outcomes through advanced molecular analysis.
Contact Information
Website
www.bioherent.comCorporate Office
- Calle Severo Ochoa Street 34
- Campanillas
- 29590 Malaga
- Spain
Corporate Office
- Calle Severo Ochoa Street 34
- Campanillas
- 29590 Malaga
- Spain
Bioherent Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 17-Jul-2025 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 26-Jul-2021 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Bioherent Patents
Bioherent Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4760238-A1 | Method and system for the readout of photonic integrated circuits | Pending | 10-Dec-2024 | ||
| WO-2026125262-A1 | Method and system for the readout of photonic integrated circuits | Pending | 10-Dec-2024 |
Bioherent Signals
Bioherent Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axon Partners Group | Growth/Expansion | Minority | ||
| Bullnet Capital | Venture Capital | Minority | ||
| CDTI Invierte | Venture Capital | Minority | ||
| University of Malaga | University | Minority |
Bioherent FAQs
-
When was Bioherent founded?
Bioherent was founded in 2021.
-
Where is Bioherent headquartered?
Bioherent is headquartered in Malaga, Spain.
-
What is the size of Bioherent?
Bioherent has 14 total employees.
-
What industry is Bioherent in?
Bioherent’s primary industry is Drug Discovery.
-
Is Bioherent a private or public company?
Bioherent is a Private company.
-
What is Bioherent’s current revenue?
The current revenue for Bioherent is .
-
How much funding has Bioherent raised over time?
Bioherent has raised $3.43M.
-
Who are Bioherent’s investors?
Axon Partners Group, Bullnet Capital, CDTI Invierte, and University of Malaga have invested in Bioherent.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process